Nomura Holdings’s Ironwood Pharmaceuticals IRWD Stock Holding History

Nomura Holdings’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-500,000	Closed	-$6.66M	–	2347
2021 Q3	$6.66M	Buy	+500,000	New	+$6.46M	0.02%	532

Other funds holding IRWD

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Nomura Holdings's IRWD Position: Q1 2025 in Review

Nomura Holdings sold out of Ironwood Pharmaceuticals (IRWD) in Q1 2025, closing a stake of 23,852 shares — an estimated $106K sold.

Nomura Holdings first reported a position in IRWD in Q2 2013 and held it in 11 quarters. The position peaked at $2.44M in Q2 2018. 200 funds tracked by Wall St. Rank hold IRWD as of Q1 2025.

Nomura Holdings reported no remaining Ironwood Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
Nomura Holdings sold 23,852 Ironwood Pharmaceuticals shares in Q1 2025, an estimated $106K.
Nomura Holdings first reported a position in Ironwood Pharmaceuticals in Q2 2013 and held it in 11 quarters.
Nomura Holdings's Ironwood Pharmaceuticals position peaked at $2.44M in Q2 2018.
200 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2025.

Based on Nomura Holdings's 13F filing for Q1 2025, filed 15 May 2025.